Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 0.77991675
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

6.74 -0.05 (-0.74%)

71.20% Fall from 52W High

2.0M

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Capricor Therapeutics Inc is on 07 Aug 2025 for the purpose of Capricor Therapeutics Inc Second Quarter Earnings Results for 2025 See details